A Pilot Study to Evaluate Nipple-Areolar Complex (NAC) Sparing Mastectomy
Completed
Conditions studied: Breast Cancer
In brief
The goal of this study is to study nipple-areolar complex (NAC) sparing mastectomy as an alternative procedure to the standard skin-sparing mastectomy for women who have breast cancer or are at high-risk for developing breast cancer. You have been asked to take part in this study because your treating surgeon feels you are a candidate for skin-sparing mastectomy and because you want breast reconstruction after surgery. Outcomes that will be measured include how much nipple sensation can be kept after surgery; how satisfied you are with how the breast looks after surgery; complication rates; and your quality-of-life.
Key facts
- Study ID
- NCT00539227
- Run by
- M.D. Anderson Cancer Center
- People needed
- 37
- Starts
- 2007-10-01
- Expected to finish
- 2013-07-01
- Last updated by the study team
- 2013-08-26
Who can join
Age: any. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Patients desiring prophylactic mastectomy with immediate reconstruction
- Patients with Stage 0, I, or II breast cancer who are candidates for and desire skin-sparing mastectomy with immediate reconstruction
- Tumor location greater than or equal to 2.5 cm from the border of the NAC based on preoperative imaging and/or clinical exam
- Patients must sign an informed consent and be registered before the procedure is performed
You may not qualify if…
- Patients with cancer involvement of the NAC on clinical exam, defined as induration, retraction, fixation, ulceration, or pathologic nipple discharge
- Patients with subareolar tumor locations, tumors located < 2.5 cm from the border of the NAC
- Patients with Paget's disease of the nipple
- Patients who have locally advanced breast cancer manifesting as inflammatory breast cancer or gross involvement of the mastectomy skin
- Patients with history of prior surgery involving a periareolar incision
- Patients desiring a concomitant ipsilateral reduction mammoplasty at time of mastectomy
- Patients with macromastia as defined by the plastic surgeon
- Patients with a body mass index (BMI) greater than 40 kg/m2
- Patients who actively smoke
- Patients with known collagen vascular disease
- Patients with prior ipsilateral chest wall irradiation less than 12 months from their time of surgery
Where it is running
- UT MD Anderson Cancer Center — Houston, Texas, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.